Last 12 months
Inside the activity.
0 purchase rows · 18 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 10 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 07, 2024 Filed Jun 11, 2024 20:20 UTC |
Okey StephanieDirector
|
GrantCommon Stock | 3,400 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-071928 · ownership.xml · nonDerivative · entry 1 Okey Stephanie · CIK 0001742616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,400 F1 · price: The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 100% vesting on the earlier of the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| June 07, 2024 Filed Jun 11, 2024 20:21 UTC |
Vivaldi Coelho RogerioDirector
|
GrantStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $44.71 | $0.00 |
DisclosureSEC source: 0000950170-24-071930 · ownership.xml · derivative · entry 2 Vivaldi Coelho Rogerio · CIK 0001610381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2034-06-07 F2 · derivative.exercise_date: The stock option shall vest and become exercisable on the earlier of the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| June 07, 2024 Filed Jun 11, 2024 20:21 UTC |
Vivaldi Coelho RogerioDirector
|
GrantCommon Stock | 3,400 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-071930 · ownership.xml · nonDerivative · entry 1 Vivaldi Coelho Rogerio · CIK 0001610381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,400 F1 · price: The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 100% vesting on the earlier of the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| June 07, 2024 Filed Jun 11, 2024 20:20 UTC |
Nichols WestonDirector
|
GrantStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $44.71 | $0.00 |
DisclosureSEC source: 0000950170-24-071926 · ownership.xml · derivative · entry 2 Nichols Weston · CIK 0001746376 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2034-06-07 F2 · derivative.exercise_date: The stock option shall vest and become exercisable on the earlier of the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| June 07, 2024 Filed Jun 11, 2024 20:20 UTC |
Nichols WestonDirector
|
GrantCommon Stock | 3,400 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-071926 · ownership.xml · nonDerivative · entry 1 Nichols Weston · CIK 0001746376 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,400 F1 · price: The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 100% vesting on the earlier of the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| June 07, 2024 Filed Jun 11, 2024 20:19 UTC |
Bedrosian Camille LDirector
|
GrantStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $44.71 | $0.00 |
DisclosureSEC source: 0000950170-24-071923 · ownership.xml · derivative · entry 2 Bedrosian Camille L · CIK 0001326969 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2034-06-07 F2 · derivative.exercise_date: The stock option shall vest and become exercisable on the earlier of the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| June 07, 2024 Filed Jun 11, 2024 20:19 UTC |
Bedrosian Camille LDirector
|
GrantCommon Stock | 3,400 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-071923 · ownership.xml · nonDerivative · entry 1 Bedrosian Camille L · CIK 0001326969 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,400 F1 · price: The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 100% vesting on the earlier of the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| June 07, 2024 Filed Jun 11, 2024 20:19 UTC |
Fust Matthew KDirector
|
GrantStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $44.71 | $0.00 |
DisclosureSEC source: 0000950170-24-071924 · ownership.xml · derivative · entry 2 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2034-06-07 F2 · derivative.exercise_date: The stock option shall vest and become exercisable on the earlier of the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| June 07, 2024 Filed Jun 11, 2024 20:19 UTC |
Fust Matthew KDirector
|
GrantCommon Stock | 3,400 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-071924 · ownership.xml · nonDerivative · entry 1 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,936 F1 · price: The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 100% vesting on the earlier of the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| June 07, 2024 Filed Jun 11, 2024 20:18 UTC |
WIERENGA WENDALLDirector
|
GrantStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $44.71 | $0.00 |
DisclosureSEC source: 0000950170-24-071921 · ownership.xml · derivative · entry 2 WIERENGA WENDALL · CIK 0001235945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2034-06-07 F2 · derivative.exercise_date: The stock option shall vest and become exercisable on the earlier of the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| June 07, 2024 Filed Jun 11, 2024 20:18 UTC |
WIERENGA WENDALLDirector
|
GrantCommon Stock | 3,400 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-071921 · ownership.xml · nonDerivative · entry 1 WIERENGA WENDALL · CIK 0001235945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,246 F1 · price: The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 100% vesting on the earlier of the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| May 28, 2024 Filed May 30, 2024 20:28 UTC |
Betz Stephen F.Chief Scientific Officer
|
SaleCommon Stock | 3,000 | $47.49 | $142,470.00 |
DisclosureSEC source: 0000950170-24-066657 · ownership.xml · nonDerivative · entry 1 Betz Stephen F. · CIK 0001886575 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 86,643 F1 · kind: The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $47.49 per share. The range of sales prices on the transaction date was $47.24 to $48.01 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request. Read SEC document |
| May 10, 2024 Filed May 14, 2024 22:29 UTC |
Betz Stephen F.Chief Scientific Officer
|
SaleCommon Stock | 3,000 | $49.43 | $148,290.00 |
DisclosureSEC source: 0000950170-24-059865 · ownership.xml · nonDerivative · entry 1 Betz Stephen F. · CIK 0001886575 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 89,643 F1 · kind: The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| May 08, 2024 Filed May 10, 2024 20:57 UTC |
Struthers Richard ScottDirector · President & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 107,448 | $0.00 Strike: $9.28 | $0.00 |
DisclosureSEC source: 0000950170-24-057926 · ownership.xml · derivative · entry 8 Struthers Richard Scott · CIK 0001746298 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,342 Underlying: Common Stock · 107,448 shares Expires 2028-05-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/48th of the shares subject to the option vested on June 25, 2018, and 1/48th of the shares subject to the option vested monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| May 08, 2024 Filed May 10, 2024 20:57 UTC |
Struthers Richard ScottDirector · President & CEO
|
SaleCommon Stock | 107,448 | $49.40 | $5,307,931.20 |
DisclosureSEC source: 0000950170-24-057926 · ownership.xml · nonDerivative · entry 2 Struthers Richard Scott · CIK 0001746298 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 257,485 F1 · kind: The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan entered into in March 2023. F2 · price: The common stock was sold by the reporting person in open market transactions on the transaction date, with a weighted average sales price of $49.40 per share. The range of sales prices on the transaction date was $48.95 to $50.15 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request. Read SEC document |
| May 08, 2024 Filed May 10, 2024 20:57 UTC |
Struthers Richard ScottDirector · President & CEO
|
Exercise / conversionCommon Stock | 107,448 | $9.28 | $997,117.44 |
DisclosureSEC source: 0000950170-24-057926 · ownership.xml · nonDerivative · entry 1 Struthers Richard Scott · CIK 0001746298 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 364,933 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 18, 2024 Filed Apr 22, 2024 21:23 UTC |
Struthers Richard ScottDirector · President & CEO
|
GiftCommon Stock | 350 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-046523 · ownership.xml · nonDerivative · entry 1 Struthers Richard Scott · CIK 0001746298 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 257,485 F1 · kind: Bona fide gift made by the Reporting Person for no consideration. Read SEC document |
| April 15, 2024 Filed Apr 17, 2024 16:36 UTC |
Pizzuti DanaChief Med and Dev Officer
|
Exercise / conversionStock option (Right to Buy) · Derivative | 14,375 | $0.00 Strike: $16.89 | $0.00 |
DisclosureSEC source: 0000950170-24-045142 · ownership.xml · derivative · entry 3 Pizzuti Dana · CIK 0001948238 · Chief Med and Dev Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 177,292 Underlying: Common Stock · 14,375 shares Expires 2032-10-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is exercisable as follows: 25% of the shares subject to the option vest on September 30, 2023, and the remaining number of shares subject to the option vest monthly thereafter in thirty-six equal monthly installments, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| April 15, 2024 Filed Apr 17, 2024 16:36 UTC |
Pizzuti DanaChief Med and Dev Officer
|
SaleCommon Stock | 14,375 | $44.47 | $639,256.25 |
DisclosureSEC source: 0000950170-24-045142 · ownership.xml · nonDerivative · entry 2 Pizzuti Dana · CIK 0001948238 · Chief Med and Dev Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,786 F1 · kind: The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $44.47 per share. The range of sales prices on the transaction date was $43.98 to $44.75 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request. Read SEC document |
| April 15, 2024 Filed Apr 17, 2024 16:36 UTC |
Pizzuti DanaChief Med and Dev Officer
|
Exercise / conversionCommon Stock | 14,375 | $16.89 | $242,793.75 |
DisclosureSEC source: 0000950170-24-045142 · ownership.xml · nonDerivative · entry 1 Pizzuti Dana · CIK 0001948238 · Chief Med and Dev Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,161 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 15, 2024 Filed Apr 17, 2024 20:30 UTC |
Struthers Richard ScottDirector · President & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $1.91 | $0.00 |
DisclosureSEC source: 0000950170-24-045136 · ownership.xml · derivative · entry 7 Struthers Richard Scott · CIK 0001746298 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,270 Underlying: Common Stock · 20,000 shares Expires 2028-03-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 1/48th of the shares subject to the option vested on April 16, 2018, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| April 15, 2024 Filed Apr 17, 2024 20:30 UTC |
Struthers Richard ScottDirector · President & CEO
|
Exercise / conversionCommon Stock | 20,000 | $1.91 | $38,200.00 |
DisclosureSEC source: 0000950170-24-045136 · ownership.xml · nonDerivative · entry 1 Struthers Richard Scott · CIK 0001746298 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 257,835 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 04, 2024 Filed Apr 8, 2024 21:09 UTC |
Struthers Richard ScottDirector · President & CEO
|
Exercise / conversionNon-qualified stock option (Right to Buy) · Derivative | 40,951 | $0.00 Strike: $9.28 | $0.00 |
DisclosureSEC source: 0000950170-24-042681 · ownership.xml · derivative · entry 8 Struthers Richard Scott · CIK 0001746298 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 123,790 Underlying: Common Stock · 40,951 shares Expires 2028-05-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/48th of the shares subject to the option vested on June 25, 2018, and 1/48th of the shares subject to the option vested monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| April 04, 2024 Filed Apr 8, 2024 21:09 UTC |
Struthers Richard ScottDirector · President & CEO
|
SaleCommon Stock | 40,951 | $49.17 | $2,013,560.67 |
DisclosureSEC source: 0000950170-24-042681 · ownership.xml · nonDerivative · entry 2 Struthers Richard Scott · CIK 0001746298 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 237,835 F1 · kind: The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan. F2 · price: The common stock was sold by the reporting person in open market transactions on the transaction date, with a weighted average sales price of $49.17 per share. The range of sales prices on the transaction date was $48.95 to $49.56 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request. Read SEC document |
| April 04, 2024 Filed Apr 8, 2024 21:09 UTC |
Struthers Richard ScottDirector · President & CEO
|
Exercise / conversionCommon Stock | 40,951 | $9.28 | $380,025.28 |
DisclosureSEC source: 0000950170-24-042681 · ownership.xml · nonDerivative · entry 1 Struthers Richard Scott · CIK 0001746298 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 278,786 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 28, 2024 Filed Apr 2, 2024 20:35 UTC |
Okey StephanieDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 17,500 | $0.00 Strike: $18.29 | $0.00 |
DisclosureSEC source: 0001209191-24-005184 · doc4.xml · derivative · entry 3 Okey Stephanie · CIK 0001742616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,500 shares Expires 2032-06-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option shall vest and become exercisable on the earlier of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| March 28, 2024 Filed Apr 2, 2024 20:35 UTC |
Okey StephanieDirector
|
SaleCommon Stock | 17,500 | $46.38 | $811,650.00 |
DisclosureSEC source: 0001209191-24-005184 · doc4.xml · nonDerivative · entry 2 Okey Stephanie · CIK 0001742616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,000 F1 · price: The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $46.38 per share. The range of sales prices on the transaction date was $46.06 to $46.66 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request. Read SEC document |
| March 28, 2024 Filed Apr 2, 2024 20:35 UTC |
Okey StephanieDirector
|
Exercise / conversionCommon Stock | 17,500 | $18.29 | $320,075.00 |
DisclosureSEC source: 0001209191-24-005184 · doc4.xml · nonDerivative · entry 1 Okey Stephanie · CIK 0001742616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 22, 2024 Filed Mar 26, 2024 20:30 UTC |
Knight Jeff E.Chief Operating Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $23.98 | $0.00 |
DisclosureSEC source: 0001209191-24-005081 · doc4.xml · derivative · entry 4 Knight Jeff E. · CIK 0001881007 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,000 Underlying: Common Stock · 30,000 shares Expires 2031-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is exercisable as follows: 25% of the shares subject to the option vest on August 30, 2022, and the remaining number of shares subject to the option vest monthly thereafter in thirty-six equal installments, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| March 22, 2024 Filed Mar 26, 2024 20:30 UTC |
Knight Jeff E.Chief Operating Officer
|
SaleCommon Stock | 2,359 | $45.39 | $107,075.01 |
DisclosureSEC source: 0001209191-24-005081 · doc4.xml · nonDerivative · entry 3 Knight Jeff E. · CIK 0001881007 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,580 Read SEC document |
| March 22, 2024 Filed Mar 26, 2024 20:30 UTC |
Knight Jeff E.Chief Operating Officer
|
SaleCommon Stock | 30,000 | $44.22 | $1,326,600.00 |
DisclosureSEC source: 0001209191-24-005081 · doc4.xml · nonDerivative · entry 2 Knight Jeff E. · CIK 0001881007 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,939 F1 · price: The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $44.22 per share. The range of sales prices on the transaction date was $44.00 to $44.52 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request. Read SEC document |
| March 22, 2024 Filed Mar 26, 2024 20:30 UTC |
Knight Jeff E.Chief Operating Officer
|
Exercise / conversionCommon Stock | 30,000 | $23.98 | $719,400.00 |
DisclosureSEC source: 0001209191-24-005081 · doc4.xml · nonDerivative · entry 1 Knight Jeff E. · CIK 0001881007 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,939 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 16:52 UTC |
Pizzuti DanaChief Med and Dev Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $16.89 | $0.00 |
DisclosureSEC source: 0001209191-24-005061 · doc4.xml · derivative · entry 7 Pizzuti Dana · CIK 0001948238 · Chief Med and Dev Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 191,667 Underlying: Common Stock · 10,000 shares Expires 2032-10-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is exercisable as follows: 25% of the shares subject to the option vest on September 30, 2023, and the remaining number of shares subject to the option vest monthly thereafter in thirty-six equal monthly installments, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 16:52 UTC |
Pizzuti DanaChief Med and Dev Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 4,375 | $0.00 Strike: $16.89 | $0.00 |
DisclosureSEC source: 0001209191-24-005061 · doc4.xml · derivative · entry 6 Pizzuti Dana · CIK 0001948238 · Chief Med and Dev Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 201,667 Underlying: Common Stock · 4,375 shares Expires 2032-10-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is exercisable as follows: 25% of the shares subject to the option vest on September 30, 2023, and the remaining number of shares subject to the option vest monthly thereafter in thirty-six equal monthly installments, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 16:52 UTC |
Pizzuti DanaChief Med and Dev Officer
|
SaleCommon Stock | 714 | $43.69 | $31,194.66 |
DisclosureSEC source: 0001209191-24-005061 · doc4.xml · nonDerivative · entry 5 Pizzuti Dana · CIK 0001948238 · Chief Med and Dev Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,786 Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 16:52 UTC |
Pizzuti DanaChief Med and Dev Officer
|
SaleCommon Stock | 10,000 | $43.28 | $432,800.00 |
DisclosureSEC source: 0001209191-24-005061 · doc4.xml · nonDerivative · entry 4 Pizzuti Dana · CIK 0001948238 · Chief Med and Dev Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,500 F1 · price: The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $43.28 per share. The range of sales prices on the transaction date was $42.70 to $43.77 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request. Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 16:52 UTC |
Pizzuti DanaChief Med and Dev Officer
|
Exercise / conversionCommon Stock | 10,000 | $16.89 | $168,900.00 |
DisclosureSEC source: 0001209191-24-005061 · doc4.xml · nonDerivative · entry 3 Pizzuti Dana · CIK 0001948238 · Chief Med and Dev Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 16:52 UTC |
Pizzuti DanaChief Med and Dev Officer
|
SaleCommon Stock | 4,375 | $45.89 | $200,768.75 |
DisclosureSEC source: 0001209191-24-005061 · doc4.xml · nonDerivative · entry 2 Pizzuti Dana · CIK 0001948238 · Chief Med and Dev Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,500 Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 16:52 UTC |
Pizzuti DanaChief Med and Dev Officer
|
Exercise / conversionCommon Stock | 4,375 | $16.89 | $73,893.75 |
DisclosureSEC source: 0001209191-24-005061 · doc4.xml · nonDerivative · entry 1 Pizzuti Dana · CIK 0001948238 · Chief Med and Dev Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 20:31 UTC |
Fust Matthew KDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 17,500 | $0.00 Strike: $18.29 | $0.00 |
DisclosureSEC source: 0001209191-24-005060 · doc4.xml · derivative · entry 12 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,500 shares Expires 2032-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option shall vest and become exercisable on the earlier of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 20:31 UTC |
Fust Matthew KDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 17,500 | $0.00 Strike: $20.23 | $0.00 |
DisclosureSEC source: 0001209191-24-005060 · doc4.xml · derivative · entry 11 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,500 shares Expires 2031-06-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option shall vest and become exercisable on the earlier of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 20:31 UTC |
Fust Matthew KDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $23.23 | $0.00 |
DisclosureSEC source: 0001209191-24-005060 · doc4.xml · derivative · entry 10 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires 2030-06-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option shall vest and become exercisable on the earlier of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 20:31 UTC |
Fust Matthew KDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $23.24 | $0.00 |
DisclosureSEC source: 0001209191-24-005060 · doc4.xml · derivative · entry 9 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires 2029-06-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option shall vest and become exercisable on the earlier of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 20:31 UTC |
Fust Matthew KDirector
|
SaleCommon Stock | 17,500 | $45.50 | $796,250.00 |
DisclosureSEC source: 0001209191-24-005060 · doc4.xml · nonDerivative · entry 8 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,536 F1 · kind: The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 20:31 UTC |
Fust Matthew KDirector
|
Exercise / conversionCommon Stock | 17,500 | $18.29 | $320,075.00 |
DisclosureSEC source: 0001209191-24-005060 · doc4.xml · nonDerivative · entry 7 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,036 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 20:31 UTC |
Fust Matthew KDirector
|
SaleCommon Stock | 17,500 | $43.58 | $762,650.00 |
DisclosureSEC source: 0001209191-24-005060 · doc4.xml · nonDerivative · entry 6 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,536 F1 · kind: The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $43.58 per share. The range of sales prices on the transaction date was $42.70 to $44.23 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request. Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 20:31 UTC |
Fust Matthew KDirector
|
Exercise / conversionCommon Stock | 17,500 | $20.23 | $354,025.00 |
DisclosureSEC source: 0001209191-24-005060 · doc4.xml · nonDerivative · entry 5 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,036 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 20:31 UTC |
Fust Matthew KDirector
|
SaleCommon Stock | 12,500 | $43.57 | $544,625.00 |
DisclosureSEC source: 0001209191-24-005060 · doc4.xml · nonDerivative · entry 4 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,536 F1 · kind: The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $43.57 per share. The range of sales prices on the transaction date was $42.70 to $44.23 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request. Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 20:31 UTC |
Fust Matthew KDirector
|
Exercise / conversionCommon Stock | 12,500 | $23.23 | $290,375.00 |
DisclosureSEC source: 0001209191-24-005060 · doc4.xml · nonDerivative · entry 3 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,036 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 20:31 UTC |
Fust Matthew KDirector
|
SaleCommon Stock | 12,500 | $43.57 | $544,625.00 |
DisclosureSEC source: 0001209191-24-005060 · doc4.xml · nonDerivative · entry 2 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,536 F1 · kind: The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $43.57 per share. The range of sales prices on the transaction date was $42.70 to $44.23 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.